Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
66.6M
-
Shares change
-
-4.73M
-
Total reported value, excl. options
-
$1.58B
-
Value change
-
-$105M
-
Put/Call ratio
-
0.13
-
Number of buys
-
74
-
Number of sells
-
-69
-
Price
-
$23.85
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q2 2021
187 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q2 2021.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.6M shares
of 170M outstanding shares and own 39.06% of the company stock.
Largest 10 shareholders include FMR LLC (12.9M shares), ARK Investment Management LLC (9.71M shares), BlackRock Inc. (6.42M shares), Sumitomo Mitsui Trust Holdings, Inc. (5.29M shares), Nikko Asset Management Americas, Inc. (5.28M shares), JANUS HENDERSON GROUP PLC (3.81M shares), STATE STREET CORP (3.46M shares), VANGUARD GROUP INC (3.41M shares), GILDER GAGNON HOWE & CO LLC (2.41M shares), and FEDERATED HERMES, INC. (2.35M shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.